Minimal/ Measurable Residual Disease
June 2022
C. Ola Landgren, M.D., Ph.D. of The Sylvester Comprehensive Cancer Center at the University of Miami Health System is a pioneer in MRD testing for blood cancers. In the videos below, he explains
- Understanding MRD (Video #1): What MRD testing is, the importance of MRD testing for cancer patients, and what it means for the future of cancer treatment
- MRD & Me (Video #2): The importance of MRD (Minimal/ Measurable Residual Disease), and how it affects a patient’s treatment course
Program Materials
We Need Your Feedback
Please complete a brief survey to help us create useful resources in the future. Thank you!
Program Support
Support provided by Amgen Inc.